Ausgabe 1/2002
Inhalt (10 Artikel)
Influence of Cimicifuga Racemosa on the Proliferation of Estrogen Receptor-Positive Human Breast Cancer Cells
Cornelia Bodinet, Johannes Freudenstein
T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases
Arnim A. Bader, Joke Tio, Edgar Petru, Michael Bühner, Annette Pfahlberg, Hildegard Volkholz, Augustinus H. Tulusan
Breast Cancers Found by Screening: Earlier Detection, Lower Malignant Potential or Both?
Miranda F. Ernst, Jan A. Roukema, Jan-Willem W. Coebergh, Ocker J. Repelaer van Driel, Mike W.P.M. van Beek, Maurice J.C. van der Sangen, Adri C. Voogd
Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database
William F. Anderson, Nilanjan Chatterjee, William B. Ershler, Otis W. Brawley
Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
Hervé Curé, Sophie Amat, Frédérique Penault-Llorca, Guillaume le Bouëdec, Jean-Pierre Ferrière, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Viviane Feillel, Jacques Dauplat, Philippe Chollet
Docetaxel Plus Vinorelbine as Salvage Chemotherapy in Advanced Breast Cancer: A Phase II Study
Javier Rodríguez, Emiliano Calvo, J. Cortes, Marta Santisteban, J. Perez-Calvo, Rafael Martínez-Monge, Antonio Brugarolas, Óscar Fernández-Hidalgo
Cyclooxygenase Inhibitors Block Cell Growth, Increase Ceramide and Inhibit Cell Cycle
Namita Kundu, Miriam J. Smyth, Leigh Samsel, Amy M. Fulton
Progesterone Receptor Quantification as a Strong Prognostic Determinant in Postmenopausal Breast Cancer Women under Tamoxifen Therapy
Pierre-Jean Lamy, Pascal Pujol, Simon Thezenas, Andrew Kramar, Philippe Rouanet, Françoise Guilleux, Jean Grenier
Predictors of Sensitivity of Clinical Breast Examination (CBE)
Nina Oestreicher, Emily White, Constance D. Lehman, Margaret T. Mandelson, Peggy L. Porter, Stephen H. Taplin